Business Description
Whitehawk Therapeutics Inc. is a clinical-stage company focused on developing cancer treatments through a portfolio of three advanced antibody drug conjugates. Founded in 2007 and headquartered in Morristown, New Jersey, the company works to better understand how tumors behave in order to improve patient outcomes. Previously operating under the name Aadi Bioscience Inc., the company rebranded to Whitehawk Therapeutics Inc. in August 2021.